<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04622215</url>
  </required_header>
  <id_info>
    <org_study_id>2018-284</org_study_id>
    <nct_id>NCT04622215</nct_id>
  </id_info>
  <brief_title>Diuresis, Functional Bladder Capacity and LUTS in CKD and ESRD Patients.</brief_title>
  <official_title>Diuresis, Functional Bladder Capacity and LUTS (Lower Urinary Tract Symptoms) in CKD (Chronic Kidney Disease) and ESRD (End Stage Renal Disease) Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the prevalence of LUTS in patients with moderate to&#xD;
      severe (Stage IIIb), severe (Stage IV) CKD and ESRD : Stage V CKD) without renal&#xD;
      transplantation (both pre-dialysis and dialysis patients). The study will also investigate&#xD;
      the correlation between the diuresis, functional bladder capacity and LUTS in this&#xD;
      population.&#xD;
&#xD;
      By means of the obtained results, the investigators hope to be able to predict at which&#xD;
      values of diuresis and functional bladder capacity these patients will start to develop LUTS.&#xD;
      The investigators will also evaluate the impact of LUTS on the quality of life of these&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pre-dialysis and peritoneal dialysis (home dialysis) and hemodialysis patients will be asked&#xD;
      to fill in a 24h voiding diary the day prior to the control visit or dialysis session, or&#xD;
      this can be registered the day of planned 24h urine collection.&#xD;
&#xD;
      All patients will be asked to fill a ICIQ-LUTS questionnaire. The ICIQ-LUTS questionnaire is&#xD;
      a validated questionnaire to investigate the presence of LUTS in a non-invasive way:&#xD;
      ICIQ-FLUTS(female lower urinary tract symptoms) for female patients and ICIQ-MLUTS(male lower&#xD;
      urinary tract symptoms) for male patients.&#xD;
&#xD;
      Following patient data will be registered:&#xD;
&#xD;
        -  Age&#xD;
&#xD;
        -  Gender&#xD;
&#xD;
        -  eGFR(estimated Glomerular Filtration Rate) (CKD-EPD)&#xD;
&#xD;
        -  Cause of CKD-ESRD&#xD;
&#xD;
        -  In case of dialysis: duration modality (hemodialysis or peritoneal dialysis)&#xD;
&#xD;
        -  Antecedents&#xD;
&#xD;
        -  Comorbidities&#xD;
&#xD;
        -  Medication&#xD;
&#xD;
        -  24h voiding diary&#xD;
&#xD;
        -  LUTS questionnaire&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">July 1, 2019</completion_date>
  <primary_completion_date type="Actual">May 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of LUTS in ESRD by ICIQ questionnaire</measure>
    <time_frame>up to 6 month</time_frame>
    <description>A ICIQ male or female LUTS questionnaire will be taken by investigator in all patient who signed IC.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>evaluation of bladder capacity in ESRD</measure>
    <time_frame>up to 6 month</time_frame>
    <description>Patient will be asked to keep an 24hour voiding diary This consist in keeping a record of the time of voiding and the volume of urine passed in ml each void. This will be measured in milliliter</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Lower Urinary Tract Symptoms</condition>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>ICIQ questionnaire</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ICIQ questionnaire</intervention_name>
    <description>questionnaire</description>
    <arm_group_label>ICIQ questionnaire</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;18years old&#xD;
&#xD;
          -  GFR(CKD-Epi) &lt; 45 ml/min and persisting minimal diuresis&#xD;
&#xD;
          -  able to read and understand Dutch, French or English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt;18 years old&#xD;
&#xD;
          -  eGFR (CKD-EPI) &gt; 45 ml/min&#xD;
&#xD;
          -  eGFR (CKD-EPI) &lt; 45 ml/min and &gt; 3 months absent persisting minimal diuresis&#xD;
&#xD;
          -  unable to read and understand Dutch, French or English&#xD;
&#xD;
          -  renal transplant recipients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>veerle de boe, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>universitair ziekenhuis VUB</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Valida</name>
      <address>
        <city>Brussel</city>
        <state>Brussels Hoofdstedelijk Gewest</state>
        <zip>1082</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>universitair ziekenhuis VUB</name>
      <address>
        <city>Jette</city>
        <state>Vlaams Brabant</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Jan Portaels</name>
      <address>
        <city>Vilvoorde</city>
        <state>Vlaams Brabant</state>
        <zip>1800</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>December 5, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>November 12, 2020</last_update_submitted>
  <last_update_submitted_qc>November 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lower Urinary Tract Symptoms</keyword>
  <keyword>End Stage Renal Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Lower Urinary Tract Symptoms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

